OPULENT PHARMA IMPURITY STOCK LIST - L
OPULENT PHARMA IMPURITY STOCK LIST
|
OPULENT PHARMA IMPURITY STOCK LIST
UPDATED OCTOBER 2019
|
||
|
Ground Floor, 8, Aagam Heritage,
Opposite Someshwara Square, Vesu, Surat, Gujarat-395007
Contact: +91-9106692785 E-mail: info@opulentpharma.com www.opulentpharma.com |
||
|
If you cannot find your product of interest……..we
offer custom synthesis support
Kindly share your inquiry by mail to info@opulentpharma.com or Call/Message/Watsapp to +91-9106692785. We shall reverst with competitive price and lead time for the same. |
||
|
|
||
|
A-Z
|
IMPURITY STOCK LIST
|
CAS NUMBER
|
|
L
|
Product: LABETALOL IMPURITIES
|
|
|
L
|
Labetalol EP Impurity A (Labetalol 1-Carboxylic Acid)
|
1391051-99-2
|
|
L
|
Labetalol EP Impurity B (Labetalol 1-Carboxylic Acid Methyl
Ester)
|
802620-01-5
33778-93-7 |
|
L
|
Labetalol EP Impurity C
|
|
|
L
|
Labetalol EP Impurity D
|
32780-65-7
|
|
L
|
Labetalol EP Impurity E (Labetalol Piperadine Dimer)
|
|
|
L
|
Labetalol EP Impurity F
|
127988-63-0
96441-14-4 |
|
L
|
Labetalol EP Impurity G
|
|
|
L
|
5-(2-(diphenethylamino)acetyl)-2-hydroxybenzamide
|
30566-92-8
|
|
L
|
Labetalol Acetonide Impurity
|
|
|
L
|
5-Acetyl-2-(phenylmethoxy)benzamide
|
75637-30-8
|
|
L
|
3-Amino-1-(4-hydroxyphenyl)butane
|
52846-75-0
|
|
L
|
Product: LACIDIPINE IMPURITIES
|
|
|
L
|
Lacidipine EP Impurity A (Lacidipine Ethyl Methyl Diester)
|
103890-81-9
|
|
L
|
Lacidipine EP Impurity B (Dehydro Lacidipine)
|
130996-24-6
|
|
L
|
2-Formylbenzoic Acid
|
119-67-5
|
|
L
|
2-Vinyl
benzaldehyde
|
28272-96-0
|
|
L
|
Product: LACOSAMIDE IMPURITIES
|
|
|
L
|
Lacosamide EP Impurity A (Lacosamide (S)-Isomer)
|
175481-37-5
|
|
L
|
Lacosamide EP Impurity B (Lacosamide O-Acetyl Impurity)
|
1318777-54-6
|
|
L
|
Lacosamide EP Impurity D (Lacosamide N-Desacetyl Impurity)
|
196601-69-1
|
|
L
|
Lacosamide EP Impurity E (Lacosamide N-Desacetyl O-Desmethyl
Impurity)
|
175481-39-7
|
|
L
|
Lacosamide EP Impurity F (Lacosamide O-Desmethyl Impurity)
|
175481-38-6
|
|
L
|
Lacosamide EP Impurity G (N-Benzylacetamide)
|
588-46-5
|
|
L
|
Lacosamide EP Impurity I ((S)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide)
|
|
|
L
|
Lacosamide EP Impurity J (Phenylmethanamine)
|
100-46-9
|
|
L
|
Lacosamide Impurity K
|
86921-49-5
|
|
L
|
Lacosamide Related Compound F
|
171623-02-2
|
|
L
|
N-Methyl Lacosamide
|
388619-64-5
|
|
L
|
N-acetyl O-methyl L-serine methyl ester
|
|
|
L
|
1,3-Dibenzyl-urea
|
1466-67-7
|
|
L
|
(R)-2-(Acetylamino)-3-methoxypropionic Acid
|
196601-67-9
|
|
L
|
Lacosamide N-Ethylcarbonyl Analog
|
1318777-56-8
|
|
L
|
Product: LAMIVUDINE IMPURITIES
|
|
|
L
|
Lamivudine
EP Impurity A (Lamivudine Acid)
|
173829-09-9
|
|
L
|
Lamivudine EP Impurity C (Acetylsalicylic Acid EP Impurity C/
Salicylic Acid/ Mesalazine EP Impurity H/ Sulfasalazine EP Impurity H)
|
69-72-7
|
|
L
|
Lamivudine
EP Impurity D (ent-Lamivudine)
|
134680-32-3
|
|
L
|
Lamivudine EP Impurity E (Cytosine/ Gemcitabine EP Impurity A)
|
71-30-7
|
|
L
|
Lamivudine EP Impurity F (Fluorouracil EP Impurity C/ Uracil)
|
66-22-8
|
|
L
|
Lamivudine EP Impurity G (Lamivudine (3S)-Sulfoxide)
|
160552-55-6
|
|
L
|
Lamivudine EP Impurity H (Lamivudine (3R)-Sulfoxide)
|
160552-54-5
|
|
L
|
Lamivudine EP Impurity J (Lamivudine Dione Impurity)
|
145986-07-8
|
|
L
|
Lamivudine 5-Epimer
|
139757-68-9
|
|
L
|
Lamivudine 2-Epimer
|
136846-20-3
|
|
L
|
Product: LAMOTRIGINE IMPURITIES
|
|
|
L
|
Lamotrigine EP Impurity A/ Lamotrigine Related Compound C
|
252186-78-0
|
|
L
|
Lamotrigine EP Impurity B & Lamotrigine EP Impurity C
Mixture
|
94213-24-8
94213-23-7 84689-20-3 |
|
L
|
Lamotrigine EP Impurity D
|
661463-79-2
|
|
L
|
Lamotrigine EP Impurity E/ Lamotrigine Related Compound B
|
50-45-3
|
|
L
|
Lamotrigine EP Impurity F/ Lamotrigine Related Compound D
|
252186-79-1
|
|
L
|
Lamotrigine EP Impurity G
|
38943-76-9
|
|
L
|
2,3-dichloro benzoyl cyanide
|
77668-42-9
|
|
L
|
2,3-Dichloro benzoyl chloride
|
2905-60-4
|
|
L
|
Hydroxyamino Lamotrigine/ Lamotrigine Hydroxyl Amine
|
|
|
L
|
Lamotrigine N2-Oxide
|
136565-76-9
|
|
L
|
Lamotrigine 3,3 Dimer Impurity
|
1797983-48-2
|
|
L
|
2,3-Dichlorobenzoic Acid Anhydride
|
252186-80-4
|
|
L
|
2,4-Dichlorobenzoyl Chloride
|
89-75-8
|
|
L
|
2,5-Dichlorobenzoyl Chloride
|
2905-61-5
|
|
L
|
3,4-Dichlorobenzoyl Chloride
|
3024-72-4
|
|
L
|
2,3-Dichlorobenzoic Anhydride
|
51417-52-8
|
|
L
|
2,4 Dichlorobenzoyl Nitrile
|
35022-43-6
|
|
L
|
2,5 Dichlorobenzoyl nitrile
|
64985-85-9
|
|
L
|
Product: LANSOPRAZOLE IMPURITIES
|
|
|
L
|
Lansoprazole EP Impurity A (Lansoprazole N-Oxide)
|
213476-12-1
|
|
L
|
Lansoprazole EP Impurity B/ Lansoprazole Related Compound A
(Lansoprazole Sulfone)
|
131926-99-3
|
|
L
|
Lansoprazole EP Impurity C/ Lansoprazole Related Compound B
(Lansoprazole Sulfide)
|
103577-40-8
|
|
L
|
Lansoprazole EP Impurity D (Rabeprazole EP Impurity K)
|
615-16-7
|
|
L
|
Lansoprazole EP Impurity E (Rabeprazole Related Compound C)
|
583-39-1
|
|
L
|
Lansoprazole EP Impurity F (Rabeprazole EP Impurity
H/Rabeprazole Related Compound F/ Rabeprazole 4-Chloro Analog)
|
168167-42-8
|
|
L
|
Lansoprazole EP Impurity F Sulfide
(4-Desmethoxypropoxyl-4-Chloro Rabeprazole Sulfide/ Lansoprazole Sulfide
4-Chloro Analog)
|
103312-62-5
|
|
L
|
Lansoprazole Sulphone N-Oxide
|
953787-54-7
|
|
L
|
Lansoprazole Sulfide N-Oxide
|
163119-30-0
|
|
L
|
Lansoprazole S-Isomer/ Levolansoprazole
|
138530-95-7
|
|
L
|
Lansoprazole Chloromethyl Impurity
|
127337-60-4
|
|
L
|
4-chloro-2-(chloromethyl)-3-methylpyridine hydrochloride
|
152402-97-6
|
|
L
|
Lansoprazole 4-Nitro Analog
|
142384-07-4
|
|
L
|
Lansoprazole 5-Hydroxy Impurity
|
131926-98-2
1329613-29-7 |
|
L
|
Lansoprazole Hydroxymethyl Impurity
|
103577-66-8
|
|
L
|
Lansoprazole Nitro Impurity
|
37699-43-7
|
|
L
|
Lansoprazole R-Isomer
|
138530-94-6
|
|
L
|
Lansoprazole Sulfide 4-Hydroxy Analog
|
131926-97-1
|
|
L
|
Lansoprazole Thioxo Impurity
|
1246819-06-6
|
|
L
|
Product: LANTHNUM CARBONATE IMPURITIES
|
|
|
L
|
Lanthanum
hydroxyl carbonate Form-I
|
|
|
L
|
Lanthanum
hydroxyl carbonate Form-II
|
|
|
L
|
Product: LATANOPROST IMPURITIES
|
|
|
L
|
Latanoprost
Related Compound A (5,6-trans-Latanoprost)
|
913258-34-1
|
|
L
|
15-Keto Latanoprost
|
135646-98-9
|
|
L
|
Latanoprost- Acid
|
41639-83-2
|
|
L
|
15-epi Latanoprost
|
145773-22-4
|
|
L
|
5-(Diphenylphosphoryl)pentanoic
acid
|
71140-70-0
|
|
L
|
Methyl
5-(diphenylphosphoryl)pentanoate
|
146964-27-4
|
|
L
|
15-Keto
Latanoprost Acid
|
369585-22-8
|
|
L
|
Product: LEFLUNOMIDE IMPURITIES
|
|
|
L
|
Leflunomide EP Impurity A/ Leflunomide Related Compound A
|
455-14-1
|
|
L
|
Leflunomide EP Impurity B/ Leflunomide Related Compound B
|
163451-81-8
|
|
L
|
Leflunomide EP Impurity C (Leflunomide-3-isomer)
|
61643-23-0
|
|
L
|
Leflunomide EP Impurity D (5-Methylisoxazole-4-carboxylic Acid)
|
42831-50-5
|
|
L
|
Leflunomide EP Impurity E (5-Desmethyl-3-methyl Leflunomide)
|
208401-20-1
|
|
L
|
Leflunomide EP Impurity F (Leflunomide-2-isomer)
|
1403564-06-6
|
|
L
|
Leflunomide EP Impurity G
(5-methyl-N-(p-tolyl)isoxazole-4-carboxamide)
|
724429-16-7
|
|
L
|
Leflunomide EP Impurity H
(2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide)
|
24522-30-3
|
|
L
|
Leflunomide Impurity (Ethyl 5-methylis/
5-METHYL-4-ISOXAZOLECARBOXYLATE)
|
51135-73-0
|
|
L
|
3-Methylisoxazole-4-carboxylic Acid
|
17153-20-7
|
|
L
|
3-Aminobenzotrifluoride
|
98-16-8
|
|
L
|
2-Aminobenzotrifluoride
|
88-17-5
|
|
L
|
Cyanoacetic Acid
|
372-09-8
|
|
L
|
Product: LENALIDOMIDE IMPURITIES
|
|
|
L
|
Methyl 2-(chloromethyl)-3-nitrobenzoate
|
1218910-61-2
|
|
L
|
Lenalidomide 4-Nitro Impurity
|
827026-45-9
|
|
L
|
5-amino-2-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic acid
|
2197420-75-8
|
|
L
|
tert-Butyl (2,6-Dioxopiperidin-3-yl)carbamate
|
31140-42-8
|
|
L
|
3-Amino-piperidine-2,6-dione
|
2686-86-4
2353-44-8 |
|
L
|
2-(4-amino-1-oxoisoindolin-2-yl)pentanedioic acid
|
295357-66-3
|
|
L
|
5-amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic acid
|
874760-69-7
|
|
L
|
2-(Bromomethyl)-3-nitrobenzoic Acid Methyl Ester
|
98475-07-1
|
|
L
|
2-(4-Amino-1-oxoisoindolin-2-yl)pentanediamide
|
2197414-55-2
|
|
L
|
dimethyl 2-(4-amino-1-oxoisoindolin-2-yl)pentanedioate
|
1198299-50-1
|
|
L
|
methyl 5-amino-2-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoate
|
1240215-87-5
|
|
L
|
methyl 5-amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoate
|
1198299-53-4
|
|
L
|
Methyl 2-Methyl-4-nitrobenzoate
|
62621-09-4
|
|
L
|
Methyl 2-(Bromomethyl)-4-nitrobenzoate
|
133446-99-8
|
|
L
|
Methyl 2-(Bromomethyl)-5-nitrobenzoate
|
90725-68-1
|
|
L
|
2-Bromomethyl-6-nitrobenzoic Acid Methyl Ester
|
61940-21-4
|
|
L
|
Product: LERCANIDIPINE IMPURITIES
|
|
|
L
|
Lercanidipine Impurity D/ Dehydro Lercanidipine
|
887769-34-8
|
|
L
|
Lercanidipine Dimethyl Ester Impurity (Nitrendipine EP Impurity
B/ Nicardipine Related Compound C/ Nicardipine Dimethyl Ester Analog/
m-Nifedipine)
|
21881-77-6
|
|
L
|
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic
acid 1-methylpropyl ester
|
74936-74-6
|
|
L
|
N-Methyl-3,3-diphenylpropylamine
|
28075-29-8
|
|
L
|
1-Chloro-2-methyl-2-propanol
|
558-42-9
|
|
L
|
Lercanidipine Acid
|
1119226-97-9
|
|
L
|
Product: LETROZOLE IMPURITIES
|
|
|
L
|
Letrozole EP Impurity A/ Letrozole Related Compound A (Iso
Letrozole)
|
112809-52-6
|
|
L
|
Letrozole EP Impurity B
|
113402-31-6
|
|
L
|
Letrozole 4-Descyano 4-Bromo Impurity
|
143030-54-0
|
|
L
|
4,4'-Methylenedibenzonitrile
|
10466-37-2
|
|
L
|
Product: LEVALBUTEROL IMPURITIES
|
|
|
L
|
Levalbuterol Related Compound B (Salbutamol EP Impurity C/
2-Deshydroxy Salbutamol/ Albuterol Related Compound A)
|
18910-68-4
|
|
L
|
Levalbuterol Related Compound D (Salbutamol EP Impurity D/
Salbutamol Aldehyde Impurity)
|
156339-88-7
|
|
L
|
Levalbuterol Related Compound E
|
69716-64-9
|
|
L
|
Levalbuterol Related Compound H (Salbutamol EP Impurity A/
Salbutamol Methyl Ether)
|
870076-72-5
|
|
L
|
Product: LEVAMISOLE IMPURITIES
|
|
|
L
|
Levamisole EP Impurity D
|
4335-28-8
|
|
L
|
Product: LEVETIRACETAM IMPURITIES
|
|
|
L
|
Levetiracetam EP Impurity A (Levetiracetam Carboxylic Acid
Racemate)
|
67118-31-4
|
|
L
|
Levetiracetam EP Impurity B
|
358629-47-7
|
|
L
|
Levetiracetam EP Impurity C
|
72762-00-6
142-08-5 |
|
L
|
Levetiracetam EP Impurity D (Levetiracetam R-Isomer)
|
103765-01-1
|
|
L
|
Levetiracetam EP Impurity E/ (R)-(+)-Phenyl ethyl amine
|
3886-69-9
|
|
L
|
Levitiracetam Related compound A
|
102767-31-7
|
|
L
|
Levitiracetam Related compound B
|
7682-20-4
|
|
L
|
Levetiracetam Impurity 3 (Piracetam EP Impurity A/ Povidone EP
Impurity B/ pyrrolidin-2-one/2-Oxo-4-butyrolactam)
|
616-45-5
|
|
L
|
Levetiracetam Racemate (Etiracetam)
|
33996-58-6
|
|
L
|
Levetiracetam Acid
|
103833-72-3
|
|
L
|
Levetiracetam Carboxylic Acid
|
102849-49-0
|
|
L
|
(S)-(-)-1-Phenylethylamine
|
2627-86-3
|
|
L
|
Product: LEVOCETRIZINE IMPURITIES
|
|
|
L
|
4-Chlorobenzhydryl Chloride
|
134-83-8
|
|
L
|
Levocetirizine Amide
|
909779-33-5
|
|
L
|
Levocetirizine Ethyl Ester
|
1116338-10-3
|
|
L
|
Product: LEVODOPA IMPURITIES
|
|
|
L
|
Levodopa EP Impurity A/ Levodopa Related Compound A (2-Hydroxy
Levodopa)
|
27244-64-0
|
|
L
|
Levodopa EP Impurity B (L-Tyrosine)
|
60-18-4
|
|
L
|
Levodopa EP Impurity C/ Levodopa Related Compound B
(3-Methyl-DL-Dopa/ 3-Methoxy-DL-tyrosine)
|
7636-26-2
|
|
L
|
Levodopa EP Impurity D (D-Dopa)
|
5796-17-8
|
|
L
|
L-Veratrylglycine (DMPA)
|
32161-30-1
|
|
L
|
Product: LEVODROPROPIZINE IMPURITIES
|
|
|
L
|
Levodropropizine EP Impurity A (Dextrodropropizine/ Dropropizine
R-Isomer)
|
99291-24-4
|
|
L
|
Levodropropizine EP Impurity B
|
92-54-6
|
|
L
|
Levodropropizine EP Impurity C (Glycidol)
|
556-52-5
|
|
L
|
Product: LEVOFLOXACIN IMPURITIES
|
|
|
L
|
Levofloxacin EP Impurity B/ Levofloxacin Related Compound A
(N-Desmethyl Levofloxacin)
|
117707-40-1
|
|
L
|
Levofloxacin EP Impurity C (Levofloxacin N-oxide/
Oxifloxacin EP Impurity F)
|
117678-38-3
117678-37-2 |
|
L
|
Levofloxacin EP Impurity D/ Levofloxacin Related Compound F
(Levofloxacin Desfluoro Impurity)
|
117620-85-6
|
|
L
|
Levofloxacin EP Impurity E (Levofloxacin Descarboxy
Impurity)
|
178964-53-9
|
|
L
|
Levofloxacin EP Impurity F/ Levofloxacin Related Compound B
(Levofloxacin Difluoro Carboxylic Acid)
|
100986-89-8
|
|
L
|
Levofloxacin EP Impurity G/ Levofloxacin Related Compound E
(Levofloxacin Desethylene Impurity)
|
1346603-62-0
|
|
L
|
Levofloxacin EP Impurity H/ Levofloxacin Related Compound C
(Levofloxacin Ethyl Ester)
|
177472-30-9
|
|
L
|
Levofloxacin EP Impurity I (Levofloxacin 9-Piperazinyl Isomer)
|
178912-62-4
|
|
L
|
Ofloxacin - Racemic mixture
|
82419-36-1
|
|
L
|
Ofloxacin R-Isomer
|
100986-86-5
|
|
L
|
Desmethyl Ofloxacin (Ofloxacin EP Impurity E)
|
82419-52-1
|
|
L
|
Levofloxacin Diamine Impurity (N,N-Didesethylene Levofloxacin)
|
1797510-34-9
1797099-76-3 |
|
L
|
2,3,4-Trifluoro-α-[[[(1S)-2-hydroxy-1-methylethyl]amino]methylene]-β-oxo-benzenepropanoic
Acid Ethyl Ester
|
601490-35-1
|
|
L
|
N,N’-Desethylene Levofloxacin Hydrochloride
|
151250-76-9
|
|
L
|
Product: LEVONORGESTREL IMPURITIES
|
|
|
L
|
Tetralone
|
1078-19-9
|
|
L
|
Product: LEVOSULPIRIDE IMPURITIES
|
|
|
L
|
(2S)-2-Aminomethyl-1-ethylpyrrolidine
|
22795-99-9
|
|
L
|
Product: LEVOTHYROXINE IMPURITIES
|
|
|
L
|
Levothyroxine EP Impurity B
|
1628720-66-0
|
|
L
|
Levothyroxine EP Impurity C/ Levothyroxine T3-Acetic Acid
(Liothyronine EP Impurity C/ Triiodothyroacetic Acid)
|
51-24-1
|
|
L
|
Levothyroxine EP Impurity D/ T4-Acetic Acid (Liothyronine EP
Impurity D/ Tetraiodothyroacetic Acid)
|
67-30-1
|
|
L
|
Levothyroxine EP Impurity E (Liothyronine EP Impurity E/
Diiodothyronine/ 3,5-Diiodo-L-thyronine)
|
1041-01-6
|
|
L
|
Levothyroxine EP Impurity F (Levothyroxine T6 Impurity)
|
911661-90-0
|
|
L
|
Levothyroxine EP Impurity H (Levothyroxine Benzoic Acid
Impurity)
|
2055-97-2
|
|
L
|
Levothyroxine EP Impurity I
|
2016-06-0
|
|
L
|
Levothyroxine EP Impurity J
|
4604-41-5
|
|
L
|
Levothyroxine EP Impurity K
|
5817-39-0
|
|
L
|
Levothyroxine T4-Acetamide Impurity
|
176258-88-1
|
|
L
|
Levothyroxine beta-Hydroxy Impurity
|
107849-54-7
|
|
L
|
Levothyroxine D-Isomer
|
51-49-0
|
|
L
|
Levothyroxine Ethyl Ester
|
76353-71-4
|
|
L
|
Levothyroxine Hydroxyphenoxy Aldehyde Impurity (3,5-Diiodo
Thyroaldehyde)
|
828-49-1
|
|
L
|
Levothyroxine Methyl Ester
|
32180-11-3
|
|
L
|
Levothyroxine N-Acetyl Impurity
|
26041-51-0
|
|
L
|
Levothyroxine N-Formyl Impurity
|
671235-41-9
|
|
L
|
Levothyroxine T4-Hydroxyacetic Acid
|
93647-48-4
|
|
L
|
L-Thyronine/ Desiodothyroxine
|
1596-67-4
|
|
L
|
Levothyroxine In house Impurity
|
5563-89-3
|
|
L
|
Product: LICARBAZEPINE IMPURITIES
|
|
|
L
|
Licarbazepine R-Isomer
|
104746-03-4
|
|
L
|
Licarbazepine Acetate R-Isomer
|
186694-45-1
|
|
L
|
Product: LIDOCAINE IMPURITIES
|
|
|
L
|
Lidocaine EP Impurity A/ Lidocaine Related Compound A
(Bupivacaine EP Impurity F/ Ropivacaine EP Impurity H/ Ropivacaine Related
Compound A/ Mepivacaine EP Impurity A)
|
87-62-7
21436-98-6 |
|
L
|
Lidocaine EP Impurity B (Lidocaine N-Oxide)
|
2903-45-9
|
|
L
|
Lidocaine EP Impurity C
|
2198-53-0
|
|
L
|
Lidocaine EP Impurity D (N-Desethyl Lidocaine/ Nor Lidocaine)
|
7728-40-7
7729-94-4 |
|
L
|
Lidocaine EP Impurity E/ Lidocaine Related Compound E (Lidocaine
Dimer Impurity)
|
745798-07-6
1135231-62-7 |
|
L
|
Lidocaine EP Impurity F (Lidocaine 2,3-Dimethyl Analog)
|
857170-72-0
|
|
L
|
Lidocaine EP Impurity G
|
42459-30-3
35891-87-3 |
|
L
|
Lidocaine EP Impurity H
|
1131-01-7
|
|
L
|
Lidocaine EP Impurity I (Lidocaine 2,4-Dimethyl Analog)
|
17289-53-1
17289-54-2 |
|
L
|
Lidocaine EP Impurity J (Lidocaine 2,5-Dimethyl Analog)
|
1012864-23-1
|
|
L
|
Lidocaine EP Impurity K (N-Desethyl-N-Methyl Lidocaine)
|
74634-66-5
50295-20-0 |
|
L
|
Glycinexylidide/ 2-Amino-N-(2,6-dimethylphenyl)acetamide
|
18865-38-8
35891-83-9 |
|
L
|
Product: LINAGLIPTIN IMPURITIES
|
|
|
L
|
Linagliptin Impurity 8 (Linagliptin N-Formyl Impurity)
|
|
|
L
|
Linagliptin Impurity 10 (S-Isomer)
|
668270-11-9
|
|
L
|
Linagliptin N-Acetyl Impurity/ Linagliptin acetamide
|
1803079-49-3
|
|
L
|
Linagliptin impurity 16
|
1911621-52-7
|
|
L
|
Linagliptin Related Compound B (N-Boc Linagliptin)
|
668273-75-4
|
|
L
|
Linagliptin 2-Chloromethyl Impurity
|
109113-72-6
|
|
L
|
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
|
853029-57-9
|
|
L
|
Linagliptin
Impurity S
|
1638744-06-5
|
|
L
|
(S)-piperidin-3-amine
dihydrochloride
|
334618-07-4
|
|
L
|
Linagliptin 8-Bromo Impurity
|
93703-24-3
|
|
L
|
Linagliptin 3-Methyl Xanthine Impurity (Pentoxifylline EP
Impurity B/ Theophylline EP Impurity B)
|
1076-22-8
|
|
L
|
Linagliptin Glucose adduct
|
|
|
L
|
Linagliptin-HBr adduct
|
|
|
L
|
Linagliptin Dimer
|
|
|
L
|
Des-Bromolinagliptin
|
|
|
L
|
7-benzyl-8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione
|
93703-26-5
|
|
L
|
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1Hpurin-2,6(3H,7H)-dione
|
666816-98-4
|
|
L
|
7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
|
586408-08-4
|
|
L
|
(4-methylquinazolin-2-yl)methanol
|
13535-91-6
|
|
L
|
7-benzyl-3-methyl-1H-purine-2,6(3H,7H)-dione
|
56025-86-6
|
|
L
|
7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
|
1646355-34-1
|
|
L
|
Linagliptin Regio-isomer
|
1446263-38-2
|
|
L
|
N-Phthalimidelinagliptin
|
886588-63-2
|
|
L
|
(R)-3-Amino-1-benzylpiperidine
|
168466-84-0
|
|
L
|
Product: LINCOMYCIN IMPURITIES
|
|
|
L
|
Lincomycin EP Impurity C (N-Desmethyl Lincomycin)
|
2256-16-8
14600-41-0 |
|
L
|
Lincomycin EP Impurity B
|
37744-65-3
|
|
L
|
Product: LINEZOLID IMPURITIES
|
|
|
L
|
Linezolid Related Compund A (Linezolid Desacetamide Azide)
|
168828-84-0
|
|
L
|
Linezolid Related Compund B (ThioLinezolid)
|
216868-57-4
|
|
L
|
Linezolid Related Compund C (Linezolid Desacetyl Analog)
|
168828-90-8
|
|
L
|
Linezolid Related Compound D (Linezolid Mesylate Impurity)
|
174649-09-3
|
|
L
|
Linezolid Benzyl Impurity
|
168828-81-7
|
|
L
|
Linezolid Amine Impurity
|
93246-53-8
|
|
L
|
Linezolid Intermediate Impurity-3
|
2689-39-6
|
|
L
|
Linezolid Desfluoro Impurity
|
556801-15-1
|
|
L
|
Linezolid R-Isomer
|
872992-20-6
|
|
L
|
Linezolid Dimer
|
908143-04-4
|
|
L
|
Linezolid N-Oxide
|
189038-36-6
|
|
L
|
Linezolid Hydroxymethyl Impurity (Linezolid Desacetamide Hydroxy
Impurity)
|
168828-82-8
|
|
L
|
3-chloro-2-hydroxypropyl butanoate
|
3478-20-4
|
|
L
|
Linezolid N-Desacetyl (R)-Isomer
|
912359-80-9
|
|
L
|
Linezolid Descarbonyl (S)-Isomer
|
1561176-27-9
|
|
L
|
Linezolid Descarbonyl N-Desacetyl N-Acetyl Impurity
|
333753-69-8
1391068-25-9 |
|
L
|
Product: LIOTHYRONINE IMPURITIES
|
|
|
L
|
Liothyronine EP Impurity A (Levothyroxine)
|
51-48-9
55-03-8 25416-65-3 |
|
L
|
Liothyronine EP Impurity B
|
300-39-0
|
|
L
|
Liothyronine EP Impurity C (Triiodothyroacetic Acid/
Levothyroxine EP Impurity C/ Levothyroxine T3-Acetic Acid)
|
51-24-1
|
|
L
|
Liothyronine EP Impurity D (Tetraiodothyroacetic Acid/
Levothyroxine EP Impurity D/ T4-Acetic Acid)
|
67-30-1
|
|
L
|
Liothyronine EP Impurity E (Levothyroxine EP Impurity E/
Diiodothyronine/ 3,5-Diiodo-L-thyronine)
|
1041-01-6
|
|
L
|
Product: LISINOPRIL IMPURITIES
|
|
|
L
|
Lisinopril EP Impurity A (Lisinopril CPP Impurity/ Lisinopril
APBA Impurity)
|
1012-05-1
|
|
L
|
Lisinopril EP Impurity B (Tizanidine EP Impurity I, Anastrozole EP Impurity F, Sultamicillin EP Impurity B)
|
104-15-4
6192-52-5 |
|
L
|
Lisinopril EP Impurity C/ Lisinopri Related Compund A
(Lisinopril (S,S,S)-Diketopiperazine)
|
328385-86-0
|
|
L
|
Lisinopril EP Impurity D (Lisinopril (S,S,R)-Diketopiperazine)
|
219677-82-4
|
|
L
|
Lisinopril EP Impurity E/ Lisinopril (1R)-Epimer (Lisinopril
(R,S,S)-Isomer)
|
85955-59-5
1356019-70-9 |
|
L
|
Lisinopril
EP Impurity F (Lisinopril Cyclohexyl Analog)
|
1132650-67-9
|
|
L
|
Lisinopril EP Impurity G (lisinopril Dimer)
|
1356839-89-8
|
|
L
|
Lisinopril EP Impurity H (Lisinopril CPP Lysine Impurity/
Lisinopril Des-Proline Impurity)
|
138247-43-5
|
|
L
|
Lisinopril EP Impurity I (N-Alkyl lisinopril)
|
927819-64-5
|
|
L
|
Product: LOMUSTINE IMPURITIES
|
|
|
L
|
Lomustine Related Compound B
|
13908-11-7
|
|
L
|
Lomustine Related Compound C
|
2387-23-7
|
|
L
|
cis-4-Hydroxy-lomustine
|
52049-26-0
|
|
L
|
trans-4-Hydroxy-lomustine
|
56239-24-8
|
|
L
|
Product: LOPERAMIDE IMPURITIES
|
|
|
L
|
Loperamide EP Impurity A
|
1391052-94-0
|
|
L
|
Loperamide EP Impurity B
|
|
|
L
|
Loperamide EP Impurity C
|
39512-49-7
|
|
L
|
Loperamide EP Impurity D
|
37743-41-2
|
|
L
|
Loperamide EP Impurity F/ Loperamide Related Compound F
(Loperamide N-Oxide)
|
106900-12-3
|
|
L
|
Loperamide EP Impurity G
|
109572-89-6
|
|
L
|
Loperamide EP Impurity H
|
61299-42-1
|
|
L
|
Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine)ammonium Bromide
|
37743-18-3
|
|
L
|
Product: LOPINAVIR IMPURITIES
|
|
|
L
|
Lopinavir 4-Oxo Analog/ Lopinavir Metabolite M1
|
192725-39-6
|
|
L
|
Lopinavir 4-Hydroxy Analog
|
357275-54-8
|
|
L
|
4,5-Dehydro(pyrimidin-2(1H)-one) Lopinavir
|
|
|
L
|
Product: LORATIDINE IMPURITIES
|
|
|
L
|
Loratidine EP Impurity A/ Loratidine Related Compound F
|
133284-74-9
|
|
L
|
Loratidine EP Impurity B/ Loratidine Related Compound C
|
31251-41-9
|
|
L
|
Loratadine EP Impurity C/ Loratadine Related Compound G
|
165739-83-3
|
|
L
|
Loratidine EP Impurity D/ Loratidine Related Compound A
(Desloratadine)
|
100643-71-8
|
|
L
|
Loratadine EP Impurity E
|
170727-59-0
|
|
L
|
Loratadine EP Impurity F
|
125743-80-8
|
|
L
|
Loratidine EP Impurity G/ Loratidine Related Compound B
(N-Methyl Desloratadine/ 8-Chloro Azatadine)
|
38092-89-6
|
|
L
|
Loratadine EP Impurity H
|
29976-53-2
|
|
L
|
Loratidine Related Compound D (Desloratadine 11-Hydroxy N-Methyl
Impurity)
|
38089-93-9
|
|
L
|
Loratidine Related Compound E (Loratadine Dichloro Impurity)
|
133330-60-6
|
|
L
|
Loratadine Related Compound I (Dehydro Loratadine)
|
133330-56-0
|
|
L
|
Loratadine impurity A (Desloratadine Deschloro Impurity/
N-Desmethyl Azatadine)
|
38092-95-4
|
|
L
|
Loratadine N-Formyl Impurity (Desloratadine Related Compound F/
Desloratadine N-Formyl Impurity)
|
117810-61-4
|
|
L
|
Desloratadine
8-Bromo-N-Methyl Impurity
|
130642-57-8
|
|
L
|
Desloratadine
Related Compound A (Desloratadine 8-Bromo Analog)
|
117796-50-6
|
|
L
|
Loratadine
8-Bromo Impurity
|
130642-60-3
|
|
L
|
Loratadine Methanone Impurity (Desloratadine Methanone Impurity/
Desloratadine Ketone Impurity)
|
119770-60-4
|
|
L
|
Loratadine N-Oxide
|
165739-62-8
|
|
L
|
Loratadine Desethoxycarbonyl 3-Hydroxy Impurity (Desloratadine
3-Hydroxy Impurity)
|
119410-08-1
|
|
L
|
Product: LORCASERIN IMPURITIES
|
|
|
L
|
(S)-Lorcaserin
|
616202-81-4
1006037-59-7 |
|
L
|
Product: LOSARTAN IMPURITIES
|
|
|
L
|
Losartan EP Impurity A
|
79047-41-9
|
|
L
|
Losartan EP Impurity B (Losartan Hydroxy Impurity/ Irbesartan
Hydroxy Impurity/ Candesartan Hydroxy Impurity)
|
160514-13-6
|
|
L
|
Losartan EP Impurity C (Losartan 5-Chloro Isomer/ Isolosartan)
|
114799-13-2
860644-28-6 |
|
L
|
Losartan EP Impurity D/ Losartan Related Compund A
|
83857-96-9
|
|
L
|
Losartan EP Impurity E (Losartan Methyl Impurity/ Irbesartan EP
Impurity E/ Irbesartan Methyl Impurity/ Candesartan Methyl Impurity)
|
120568-11-8
|
|
L
|
Losartan EP Impurity F (Losartan Isopropyl Ether)
|
1332713-64-0
|
|
L
|
Losartan EP Impurity G (Triphenylmethanol/ Trityl Alcohol/
Candesartan Trityl Alcohol Impurity/ Irbesartan Triphenylmethanol Impurity/
Zidovudine EP Impurity D)
|
76-84-6
|
|
L
|
Losartan EP Impurity H (N2-Trityl Losartan)
|
133909-99-6
|
|
L
|
Losartan EP Impurity I (O-Trityl Losartan/ Losartan Trityl
Ether)
|
1006062-28-7
|
|
L
|
Losartan EP Impurity J/ Losartan Related Compound B (Losartan
Acetate/ O-Acetyl Losartan)
|
1006062-27-6
|
|
L
|
Losartan EP Impurity K/ Losartan Related Compound C (Losartan
Aldehyde)
|
114798-36-6
|
|
L
|
Losartan EP Impurity L/ Losartan Related Compound D (Losartan
N1-Dimer ; N1-Losartanyl Losartan)
|
230971-71-8
|
|
L
|
Losartan EP Impurity M/ Losartan Related Compound E (Losartan
N2-Dimer/ N2-Losartanyl Losartan)
|
230971-72-9
|
|
L
|
Losartan Related Compound A
|
124750-67-0
|
|
L
|
Losartan Related Compound B
|
114772-55-3
|
|
L
|
Losartan
Bromo N1 Trityl Impurity/ Olmesartan Impurity
N-(Triphenylmethyl)-5-(4’-bromomethylbiphenyl-2-yl)tetrazole
|
124750-51-2
|
|
L
|
Losartan
Tritylated Dibromo Impurity/ Olmesartan Impurity 2
|
358685-13-9
|
|
L
|
Losartan Carboxylic Acid (Losartan Carboxylate)
|
124750-92-1
|
|
L
|
Losartan Dibromomethyl Impurity (Irbesartan Dibromomethyl
Impurity/ Valsartan Dibromomethyl Impurity)
|
209911-63-7
|
|
L
|
Losartan Bromo N1 Trityl Impurity
|
124750‐51‐2
|
|
L
|
Losartan Dibromo N2-Trityl Impurity (Irbesartan Dibromo
N2-Trityl Impurity/ Candesartan Dibromo N2-Trityl Impurity/ Candesartan
Dibromo TTBB Impurity/ Olmesartan Dibromo N2-Trityl Impurity/ Valsartan
Dibromo N2-Trityl Impurity)
|
151052-34-5
|
|
L
|
N1-Trityl Losartan
|
124751-00-4
|
|
L
|
Product: LOVASTATIN IMPURITIES
|
|
|
L
|
Lovastatin EP Impurity A (Pravastatin Deshydroxy Impurity/
Mevastatin/ Compactin)
|
73573-88-3
|
|
L
|
Lovastatin EP Impurity B (Lovastatin Hydroxy Acid)
|
75225-51-3
75225-50-2 |
|
L
|
Lovastatin EP Impurity C (Anhydro Lovastatin)
|
109273-98-5
|
|
L
|
Lovastatin Lactone Diol (Simvastatin EP Impurity H/ Simvastatin
Lactone Diol)
|
79952-42-4
|
|
L
|
Product: LOXAPINE IMPURITIES
|
|
|
L
|
Loxapine Related Compound A (3-Chloro Loxapine)
|
3454-96-4
|
|
L
|
Product: LUMEFANTRINE IMPURITIES
|
|
|
L
|
Lumefantrine Impurity A
|
1331642-68-2
|
|
L
|
2,7-Dichloro-9-[(4-chlorophenyl)methylene]-9H-fluorene
|
4364-35-6
|
|
L
|
Lumefantrine Desbutyl Impurity
|
355841-11-1
|
|
L
|
Product: LURASIDONE IMPURITIES
|
|
|
L
|
Lurasidone Sulfoxide
|
1809325-45-8
|
|
L
|
Lurasidone Sulfone
|
1644295-09-9
|
|
L
|
exo-2,3-Norbornanedicarboxylic Acid Monoamide
|
1365987-23-0
|
|
L
|
Lurasidone Open-Ring Acid (1S,2R,3S,4R)-Isomer
|
1644295-07-7
|
|
L
|
(+)-trans-1,2-Cyclohexanedimethanol
|
3205-34-3
|
|
L
|
exo-2,3-Norbornanedicarboximide
|
14805-29-9
|
|
L
|
3-[4-(methylsulfonyl)-1-piperazinyl]-1,2-Benzisothiazole
|
2190680-18-1
|
|
L
|
Lurasidone DBI Piperazine Impurity (Ziprasidone EP Impurity P)
|
223586-82-1
|
|
L
|
((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) dimethanesulfonate
|
186204-35-3
|
|
L
|
(1R,2R)-1,2-cyclohexanedimethanol
|
65376-05-8
|
|
L
|
3-Chloro-1,2-benzisothiazole
|
7716-66-7
|
|
L
|
Product: LYMECYCLINE IMPURITIES
|
|
|
L
|
Lymecycline EP Impurity G
|
57-62-5
64-72-2 |
|
L
|
Lymecycline EP Impurity H
|
64-75-5
|
Comments
Post a Comment